O
Oana M. Dumitrascu
Researcher at Cedars-Sinai Medical Center
Publications - 59
Citations - 612
Oana M. Dumitrascu is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Medicine & Engineering. The author has an hindex of 10, co-authored 39 publications receiving 316 citations. Previous affiliations of Oana M. Dumitrascu include Johns Hopkins University School of Medicine & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
Haoshen Shi,Yosef Koronyo,Altan Rentsendorj,Giovanna C. Regis,Julia Sheyn,Dieu-Trang Fuchs,Andrei A. Kramerov,Alexander V. Ljubimov,Oana M. Dumitrascu,Anthony Rodriguez,Ernesto Barron,David R. Hinton,Keith L. Black,Carol A. Miller,Nazanin Mirzaei,Maya Koronyo-Hamaoui +15 more
TL;DR: The identification of pericyte and PDGFRβ loss accompanying increased vascular amyloidosis in Alzheimer’s retina implies compromised blood–retinal barrier integrity and provides new targets for AD diagnosis and therapy.
Journal ArticleDOI
Still cooling after all these years: Meta-analysis of pre-clinical trials of therapeutic hypothermia for acute ischemic stroke.
TL;DR: Using several outcome measures in a variety of models and species, therapeutic hypothermia was protective compared with normothermia, with powerful and statistically significant normalized treatment effect sizes, in 60 papers comprising 216 comparisons.
Journal ArticleDOI
Acute ophthalmic artery occlusion in a COVID-19 patient on apixaban.
TL;DR: A case of ophthalmic artery occlusion (OAO) in a young patient with Covid-19 infection that was on therapeutic anticoagulation with apixaban for deep venous thrombosis (DVT), which prompted further investigations and upper and lower extremities DVTs were confirmed and managed with enoxaparin.
Journal ArticleDOI
Thrombolysis for Central Retinal Artery Occlusion in 2020: Time Is Vision!
TL;DR: Future research should focus on developing feasible retinal penumbra imaging studies that, similar to cerebral tissue viability or perfusion imaging, can be incorporated into the thrombolysis decision-making algorithm.
Journal ArticleDOI
Retinal Microvascular Abnormalities as Surrogate Markers of Cerebrovascular Ischemic Disease: A Meta-Analysis.
Oana M. Dumitrascu,Bart M. Demaerschalk,Cristina Valencia Sanchez,Diana Almader-Douglas,Cumara B. O’Carroll,Maria I. Aguilar,Patrick D. Lyden,Gyanendra Kumar +7 more
TL;DR: Focal arteriolar narrowing and retinopathy predicted CVD subtypes after risk-factor adjustment, suggesting that features different than traditional vascular risk factors, are involved in CVD pathophysiology.